These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6294258)

  • 1. Normal platelet aggregation in myotonic dystrophy.
    Bolhuis PA; Goldhoorn BG; de Groot JG
    J Neurol Sci; 1982 Nov; 56(2-3):337-42. PubMed ID: 6294258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sensitivity of platelets to adrenaline in human myotonic dystrophy.
    Bousser MG; Conard J; Lecrubier C; Samama M
    Lancet; 1975 Aug; 2(7929):307-9. PubMed ID: 50512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet aggregation and release reaction in myotonic dystrophy.
    Bornstein NM; Zahavi M; Korczyn AD; Zahavi J
    J Neurol Sci; 1988 Apr; 84(2-3):239-46. PubMed ID: 2967890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet functions, alpha 2-adrenergic receptors and cytoplasmic free calcium are normal in the myotonic dystrophy of Steinert.
    Lanza F; Cazenave JP; Hemmendinger S; Stierlé A; Tranchant C; Warter JM
    J Neurol Sci; 1987 Jun; 79(1-2):13-22. PubMed ID: 3039064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation in myotonia.
    Schapira AH; Hutton RA
    J Neurol Sci; 1985 Dec; 71(2-3):351-7. PubMed ID: 2935596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increase in platelet sensitivity to adrenaline in Steinert's disease].
    Castaigne P; Bousser MG; Lecrubier C; Conard J; Samama M
    Rev Neurol (Paris); 1977 Dec; 133(12):673-83. PubMed ID: 614678
    [No Abstract]   [Full Text] [Related]  

  • 9. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM; Limbird LE
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
    Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
    Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between collagen-adenosine diphosphate and collagen-epinephrine in platelets' aggregation: different dose response relationships.
    Razi MS; Hameed W; Habib SS; Aslam M; Ashraf R
    J Pak Med Assoc; 2009 Jun; 59(6):368-71. PubMed ID: 19534370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-tocopherol: its inhibition on human platelet aggregation.
    Fong JS
    Experientia; 1976 May; 32(5):639-41. PubMed ID: 1278322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet function and catecholamines].
    Endo Y; Miura A
    Rinsho Byori; 1989 Jan; 37(1):25-30. PubMed ID: 2542672
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine.
    Corby DG; O'Barr TP
    Dev Pharmacol Ther; 1981; 2(4):215-25. PubMed ID: 6266790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A circulating inhibitor of platelet aggregation in Bartter's syndrome.
    O'Reagan SO; Rivard GE; Mongeau JG; Robitaille PO
    Pediatrics; 1979 Dec; 64(6):939-41. PubMed ID: 117424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW; Bennett JS; Sheridan JF; Cooper RA; Shattil SJ
    J Lab Clin Med; 1976 Aug; 88(2):282-91. PubMed ID: 956686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by alpha and inhibition by beta-adrenergic stimulations of rat platelet aggregation. A comparative study with human and rabbit platelets.
    Yu SK; Latour JG
    Thromb Haemost; 1977 Jun; 37(3):413-22. PubMed ID: 578021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian variation in platelet alpha 2-adrenoceptor affinity in normal subjects.
    Mehta J; Malloy M; Lawson D; Lopez L
    Am J Cardiol; 1989 Apr; 63(13):1002-5. PubMed ID: 2539007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.